Novel naturally occurring autoantibodies attenuate α-synuclein pathology in a mouse model of Parkinson's disease.
Yiming LiTao WangLanxia MengLei JinCongcong LiuYangqiu LiangLin RenYang LiuYanshuang LiuShuang LiuTete LiYanqi LiangXiaoping ChenZhentao ZhangPublished in: Neuropathology and applied neurobiology (2022)
P21 and P22 attenuate α-synuclein pathology and are promising candidates for PD treatment.